Bevin P. Engelward, ScD



(617) 258-0260
Professor of Biological Engineering


Technology for quantification of DNA Damage and Repair
Application of In-House Mouse Models to Reveal Factors that Impact Genomic Stability


Professor Engelward began her scientific career at Yale University working in the laboratory of Thomas Steitz. She did her doctoral studies in the laboratory of Dr. Leona Samson at the Harvard School of Public Health. In 1997 she joined the faculty at MIT and was one of the founding faculty in the creation of the Department of Biological Engineering. Prof. Engelward’s work is public health-oriented and includes studies of the causes of DNA sequence rearrangements as well as the creation of novel technologies for detecting rare sequence changes in vivo and to measure genomic damage in vitro. The major objective of her work is to reveal the underlying mechanisms that drive genomic instability as a basis for contributing to improved global public health.


Recognizing that homology directed repair modulates disease susceptibility, this laboratory was the first to create a transgenic model in which rare recombinant cell fluoresce. This gave rise to many studies of environmental and genetic factors that modulate the risk of large-scale sequence rearrangements.

While studies using mouse models have been very informative, the Engelward laboratory also wanted to develop better ways to study DNA repair in humans. To study DNA damage and repair in human cells, an approach was envisioned for higher throughput analysis of DNA damage in human cells. In collaboration with the laboratory of Dr. Sangeeta Bhatia, a traditional DNA repair assay called the 'comet assay' was modernized by exploiting microfabrication techniques. The resulting DNA damage and repair platform provides better reproducibility and greatly increased throughput. This new technology is being used for many applications, including studies of epidemiology.

Taken together, work in this laboratory is at the interface between biological engineering and environmental health, with the goals of developing novel technologies, applying these technologies to accelerate basic research, and using our understanding of disease processes to inform disease prevention and mitigation.

Research Areas: 

Honors & Awards: 

Chair of the NIH Cancer Etiology Study Section, 2014
Vice President Elect of the Environmental Mutagenesis and Genomics Society, 2014
Deputy Director of the MIT Center for Environmental Health Sciences, 2013-present
National Library of Medicine, PubMed Central Advisory Committee, 2013-present
Member, NCI Cancer Etiology Study Section, 2011-present
Singapore Professor of Infectious Disease, 2011
Keynote Speaker, International Conference on Environmental Mutagens, 2011
DNA Repair Editorial Board, 2009-present
Member of the Faculty Policy Committee, 2005 – 2008
Secretary of the MIT Faculty, 2007 – 2008
Burroughs Wellcome Fund New Investigators Award in the Toxicological Sciences, 2000
Samuel A. Goldblith Career Development Professor of Toxicology, 1997